|
Rehabilitation After Hip and Knee Arthroplasty—Reply
|
Michael C. Munin, MD; Thomas E. Rudy, PhD; Nancy W. Glynn, PhD; et al |
1998 |
JAMA. 1998;280(16):1402-1403. |
Open
|
|
Rehabilitation After Hip and Knee Arthroplasty
|
Aaron M. Levine, MD |
1998 |
JAMA. 1998;280(16):1402-1403. |
Open
|
|
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
|
Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; et al |
1998 |
Arch Intern Med. 1998;158(14):1525-1531. |
Open
|
|
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
|
Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; et al |
1998 |
Arch Intern Med. 1998;158(14):1525-1531. |
Open
|
|
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
|
Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; et al |
1998 |
Arch Intern Med. 1998;158(14):1525-1531. |
Open
|
|
Role of Rifampin for Treatment of Orthopedic Implant–Related Staphylococcal Infections
|
Werner Zimmerli, MD; Andreas F. Widmer, MD, MSc; Marianne Blatter, MD; et al |
1998 |
JAMA. 1998;279(19):1537-1541. |
Open
|
|
The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin
|
Jacques R. Leclerc, MD; Michael Gent, DSc; Jack Hirsh, MD; et al |
1998 |
Arch Intern Med. 1998;158(8):873-878. |
Open
|
|
Inpatient Rehabilitation After Total Joint Replacement
|
Joseph D. Zuckerman, MD |
1998 |
JAMA. 1998;279(11):880. |
Open
|
|
Early Inpatient Rehabilitation After Elective Hip and Knee Arthroplasty
|
Michael C. Munin, MD; Thomas E. Rudy, PhD; Nancy W. Glynn, PhD; et al |
1998 |
JAMA. 1998;279(11):847-852. |
Open
|
|
Subcutaneous Low-Molecular-Weight Heparin vs Warfarin for Prophylaxis of Deep Vein Thrombosis After Hip or Knee Implantation
|
Russell D. Hull, MBBS, MSc; Gary E. Raskob, MSc; Graham F. Pineo, MD; et al |
1997 |
Arch Intern Med. 1997;157(3):298-303. |
Open
|
|
Timing of Initial Administration of Low-Molecular-Weight Heparin Prophylaxis Against Deep Vein Thrombosis in Patients Following Elective Hip Arthroplasty
|
Russell D. Hull, MBBS; Graham F. Pineo, MD; Paul D. Stein, MD; et al |
2001 |
Arch Intern Med. 2001;161(16):1952-1960. |
Open
|
|
Dalteparin vs Warfarin in Hip Arthroplasty Patients
|
Albert E. Bajjoka, PHARMD, BCPS |
2001 |
Arch Intern Med. 2001;161(5):771-778. |
Open
|
|
Dalteparin vs Warfarin in Hip Arthroplasty Patients—Reply
|
Russell Hull, MBBS, MSC; Graham Pineo, MD; Charles Francis, MD; et al |
2001 |
Arch Intern Med. 2001;161(5):771-778. |
Open
|
|
Dalteparin vs Warfarin in Hip Arthroplasty Patients—Reply
|
Russell Hull, MBBS, MSC; Graham Pineo, MD; Charles Francis, MD; et al |
2001 |
Arch Intern Med. 2001;161(5):771-778. |
Open
|
|
The Effect of Age on Pain, Function, and Quality of Life After Total Hip and Knee Arthroplasty
|
C. Allyson Jones, PhD; Donald C. Voaklander, PhD; D. William C. Johnston, MD; et al |
2001 |
Arch Intern Med. 2001;161(3):454-460. |
Open
|
|
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients
|
Russell D. Hull, MBBS, MSc; Graham F. Pineo, MD; Charles Francis, MD; et al |
2000 |
Arch Intern Med. 2000;160(14):2199-2207. |
Open
|
|
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty Patients
|
Russell D. Hull, MBBS, MSc; Graham F. Pineo, MD; Charles Francis, MD; et al |
2000 |
Arch Intern Med. 2000;160(14):2208-2215. |
Open
|
|
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients
|
Russell D. Hull, MBBS, MSc; Graham F. Pineo, MD; Charles Francis, MD; et al |
2000 |
Arch Intern Med. 2000;160(14):2199-2207. |
Open
|
|
Postthrombotic Syndrome After Hip or Knee Arthroplasty
|
Jeffrey S. Ginsberg, MD; M. Gent, DSc; F. Turkstra, MD; et al |
2000 |
Arch Intern Med. 2000;160(5):669-672. |
Open
|
|
Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty
|
Martin O'Donnell, MB, MRCPI; Lori-Ann Linkins, MD, FRCPC; Clive Kearon, MB, MRCPI, FRCPC, PhD; et al |
2003 |
Arch Intern Med. 2003;163(11):1362-1366. |
Open
|
|
A 57-Year-Old Man With Osteoarthritis of the Knee
|
Jess H. Lonner, MD, Discussant |
2003 |
JAMA. 2003;289(8):1016-1025. |
Open
|
|
A 57-Year-Old Man With Osteoarthritis of the Knee
|
Jess H. Lonner, MD, Discussant |
2003 |
AMA. 2003;289(8):1016-1025. |
Open
|
|
Extended Venous Thromboembolism Prophylaxis After Total Hip Replacement
|
Charles Marc Samama, MD, PhD; Muriel Vray, PhD; Jeanne Barré, MD; et al |
2002 |
Arch Intern Med. 2002;162(19):2191-2196. |
Open
|
|
Prolonged Thromboprophylaxis With Oral Anticoagulants After Total Hip Arthroplasty
|
Paolo Prandoni, MD, PhD; Olinto Bruchi, MD; Paola Sabbion, MD; et al |
2002 |
Arch Intern Med. 2002;162(17):1966-1971. |
Open
|
|
The Potential Role of Fondaparinux as Venous Thromboembolism Prophylaxis After Total Hip or Knee Replacement or Hip Fracture Surgery
|
John A. Heit, MD |
2002 |
Arch Intern Med. 2002;162(16):1806-1808. |
Open
|